09 Sep2026
BlackRock American Income Trust – Gathering momentum
09 Sep2026
BlackRock American Income Trust – Gathering momentum
09 Sep2026
BlackRock American Income Trust – Gathering momentum?
27 Aug2026
Oakley Capital Investments – On the right side of AI
27 Aug2026
Oakley Capital Investments – On the right side of AI
Pacific Horizon Investment Trust (PHI) delivered a 65.1% NAV total return in the year to 31 July 2026, almost 30 percentage points ahead of its benchmark, as its exposure to Asian semiconductor and artificial intelligence companies paid off. The performance represented a dramatic turnaround from the previous financial year, when PHI’s NAV return of 8.3% […]
Foresight Solar Fund (FSFL) has stepped up its efforts to address its persistent discount to NAV, with the board saying change needs to be accelerated and that it is considering all strategic options to maximise shareholder value. The comments accompanied half-year results showing NAV per share fell 4.3% from 99.2p at the end of December […]
Target Healthcare REIT (THRL) has delivered its best annual financial performance since launching in 2013, helped by inflation-linked rental growth, rising property values and profitable asset sales. The specialist care home investor generated a total accounting return of 12.0% in the year to 30 June 2026, up from 9.3% last year. EPRA net tangible assets […]
Octopus Renewables Infrastructure Trust (ORIT) reported a NAV total return of -5.0% for the first half of 2026 after a review of expected generation from its onshore wind assets knocked £30.4m off valuations. NAV per share fell from 93.8p to 86.2p, also reflecting lower long-term power price forecasts and higher discount rates. However, underlying cash […]
CQS New City High Yield Fund (NCYF) delivered a NAV total return of 10.2% for the year to 30 June 2026, while its share price returned 10.1%. NAV per share edged up to 48.55p from 48.37p, while the shares ended the period at 51.80p, leaving the trust trading at a 6.7% premium. That premium allowed […]
Syncona (SYNC) has announced a major clinical milestone at portfolio company Beacon Therapeutics after its gene therapy, laru-zova, delivered a positive topline result in the pivotal Phase II/III VISTA trial for X-linked retinitis pigmentosa (XLRP). The trial met its FDA-endorsed primary endpoint, with laru-zova demonstrating a statistically significant improvement in low luminance visual acuity compared […]
North Atlantic Smaller Companies Investment Trust (NAS) reported a 7.7% increase in NAV over the six months to 31 July 2026, while the share price rose by 18.1% as the discount narrowed materially. NAV per share increased from 555.4p at the end of January to 598.1p, while adjusted NAV (which reflects Oryx International Growth Fund […]
Infrastructure Capital Advisors has launched an actively managed ETF combining US equities with an options strategy designed to generate monthly income while also seeking capital growth. The Infrastructure Capital S&P 500 Option Income UCITS ETF, launched with HANetf, begins trading on the London Stock Exchange today, 18 September. The Ireland-domiciled fund has a total expense […]
Find out about investor events near you
A gateway to a library of useful information to help cut through the jargon
Sign up for our free equity research notes sent straight to your inbox
Access daily updated company fact sheets and peer group analysis tools
